Shimao Group plans to sell Hong Kong real estate projects with a valuation of HK $17.7 billion

EqualOcean Releases the 'EqualOcean 2025 GoGlobal Service Enablers TOP 50'

EqualOcean released the "EqualOcean 2025 GoGlobal Service Enablers TOP 50", selecting 50 representative companies across different segments and sectors, to record and pay tribute to their contributions in advancing the globalization of Chinese enterprises.

Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million

Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.

Drug Farm Raises $55 Million in First Closing of Series D Financing

According to EO (亿欧), Drug Farm (药物牧场) announced on July 13 that it had raised $55 million in the first closing of its Series D financing round.

Chinese Modular Buildings Attract Overseas Orders with Faster Construction

Chinese manufacturers of modular buildings are reporting growing international demand as overseas customers seek faster and more predictable ways to construct homes, hotels, data centers and public facilities.

EqualOcean Releases 2026 Chinese GoGlobal HealthTech Brands Top 10 at GGF2026

SHANGHAI, June 11, 2026 — EqualOcean officially released its 2026 Chinese GoGlobal HealthTech Brands Top 10 during the GoGlobal Forum of 100 2026 (GGF2026), one of China’s leading annual forums dedicated to globalization and international business expansion.